WOBURN, Mass., January 3, 2019 –
Frequency Therapeutics, a clinical stage biotechnology company, a clinical-stage biotechnology company, today announced that the Company will present at the upcoming 37th Annual JP Morgan Healthcare Conference in San Francisco on Monday, January 7, 2019.
David Lucchino, Co-Founder and Chief Executive Officer of Frequency, will provide an overview of the company, its innovative platform, and its clinical stage asset for Hearing Regeneration.
Presentation details are as follows:
Date: Monday, January 7, 2019
Time: 12:00 p.m. PT
Location: Westin St. Francis, Elizabethan C/D
http://www.frequencytx.com/news-events/news-events-press-release-01-03-2019.php